Moderna shares soared Tuesday as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu ...
HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...
Stock price can fluctuate for any narrative reasons but in the long run the market will always peg it to the performance.